Patients Experiences of Rehabilitation After Reverse Shoulder Arthroplasty
Launched by VASTRA GOTALAND REGION · Mar 19, 2025
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
Surgery with total shoulder arthroplasty is a procedure that has increased in number in the last twenty years, and it is the third most common prosthetic surgery in the world after hip and knee. There are two types of shoulder arthroplasty, anatomical and reverse. When the rotator cuff is severely impaired or completely dysfunctional, a reverse shoulder prosthesis is used, in which the anatomical positions of the ball and socket are reversed.
There are thus several factors that the treating physiotherapist needs to take into account. Research on reverse shoulder arthroplasty has primarily ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The inclusion criteria encompassed patients who had undergone elective surgery involving reverse shoulder arthroplasty in the Västra Götaland region who demonstrated proficiency in both spoken and written Swedish.
- Exclusion Criteria:
- • Exclusion criteria applied to cases where the study leader had served as the patient's physiotherapist, the presence of neurological disorders, or the occurrence of surgical complications, such as infection or fracture.
About Vastra Gotaland Region
Vastra Gotaland Region is a prominent healthcare organization in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a sponsor, the region leverages its extensive network of hospitals and healthcare professionals to facilitate high-quality research initiatives that address pressing health challenges. With a commitment to ethical standards and patient safety, Vastra Gotaland Region strives to foster collaboration between researchers, clinicians, and patients, ensuring that clinical trials contribute valuable insights and advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alingsås, Västra Götaland, Sweden
Patients applied
Trial Officials
Anette Larsson, RPT, PhD
Study Chair
Research, Education, Development & Innovation, Primary Health Care, Region Västra Götaland, Sweden.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported